Rivera, Carlos
Lee, Hun-Goo
Lappala, Anna
Wang, Danni http://orcid.org/0000-0002-4596-0692
Noches, Verónica
Olivares-Costa, Montserrat http://orcid.org/0000-0002-2182-2164
Sjöberg-Herrera, Marcela http://orcid.org/0000-0001-7173-048X
Lee, Jeannie T. http://orcid.org/0000-0001-7786-8850
Andrés, María Estela http://orcid.org/0000-0002-2078-2770
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01-HD097665)
FRAXA Research Foundation
Fondo Nacional de Desarrollo Científico y Tecnológico (1191152)
Article History
Received: 29 October 2020
Accepted: 1 March 2022
First Online: 23 March 2022
Competing interests
: J.T.L. is a co-founder of Translate Bio and Fulcrum Therapeutics, and also serves as Advisor to Skyhawk Therapeutics. The remaining authors declare no competing interests.